A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors
- PMID: 9150366
- DOI: 10.1038/sj.onc.1201013
A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors
Abstract
Chromosomal regions of allelic imbalance in tumors are predicted to define the general location of tumor suppressor genes. We previously localized a putative breast tumor suppressor gene to a 3 cM region on 17q25 by deletion mapping of microsatellite markers in breast tumors. To determine if the same 17q25 region of loss is important in the genesis of other tumor types, 32 ovarian tumors and 24 prostate tumors, as well as 33 additional breast tumors, were analysed with 17q25 polymorphic microsatellite markers. While no significant loss was observed in prostate tumors, greater than half of ovarian tumors exhibited loss coincident with the candidate region previously defined in breast tumors. These results suggest that one or more novel tumor suppressor genes exist on 17q25 within a concordant region of interstitial loss defined in both breast and ovarian neoplasms.
Similar articles
-
Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25.Genes Chromosomes Cancer. 1996 Sep;17(1):64-8. doi: 10.1002/(SICI)1098-2264(199609)17:1<64::AID-GCC10>3.0.CO;2-H. Genes Chromosomes Cancer. 1996. PMID: 8889509
-
Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.Cancer Res. 1993 Jul 15;53(14):3382-5. Cancer Res. 1993. PMID: 8100738
-
Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.Oncogene. 2000 Mar 9;19(11):1466-72. doi: 10.1038/sj.onc.1203463. Oncogene. 2000. PMID: 10723138
-
[Sex chromatin in the cells of tumors of the uterus, ovaries and mammary glands (Review)].Pediatr Akus Ginekol. 1967 Jul-Aug;4:35-8. Pediatr Akus Ginekol. 1967. PMID: 4904793 Review. Ukrainian. No abstract available.
-
Molecular genetic events in the development and progression of ovarian cancer in humans.Mol Med Today. 1997 May;3(5):207-13. doi: 10.1016/s1357-4310(97)01043-5. Mol Med Today. 1997. PMID: 9176883 Review.
Cited by
-
Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity.Mol Cell Biol. 2000 Nov;20(22):8352-63. doi: 10.1128/MCB.20.22.8352-8363.2000. Mol Cell Biol. 2000. PMID: 11046132 Free PMC article.
-
Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.Mamm Genome. 2007 Nov;18(11):796-807. doi: 10.1007/s00335-007-9065-x. Epub 2007 Oct 6. Mamm Genome. 2007. PMID: 17922164
-
Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Br J Cancer. 2001 Dec 14;85(12):1894-9. doi: 10.1054/bjoc.2001.2159. Br J Cancer. 2001. PMID: 11747332 Free PMC article.
-
Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.Breast Cancer Res. 2008;10(1):R5. doi: 10.1186/bcr1846. Epub 2008 Jan 11. Breast Cancer Res. 2008. PMID: 18190691 Free PMC article.
-
Applying circulating tumor DNA methylation in the diagnosis of lung cancer.Precis Clin Med. 2019 Mar;2(1):45-56. doi: 10.1093/pcmedi/pbz003. Epub 2019 Mar 15. Precis Clin Med. 2019. PMID: 35694699 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical